Mustafa Özdoğan
- Oncology top 5%
- Cancer Treatment and Pharmacology 7
- Cancer Diagnosis and Treatment 6
- Cancer survivorship and care 5
- HER2/EGFR in Cancer Research 5
- Internal Medicine top 5%
- Genetics top 10%
-
- Lung Cancer Treatments and Mutations 11
- Gastric Cancer Management and Outcomes 5
- Lung Cancer Diagnosis and Treatment 5
-
- Breast Cancer Treatment Studies 6
- Co-authors
- Erkan ÇobanG. YaziciogluAyşen TimurağaoğluBurhan SavaşHakan BozcukMehmet ArtaçMustafa SamurErdinç Nayır
- Journals
- Journal of Clinical Oncology (8 papers)SHILAP Revista de lepidopterología (10 papers)Cancer (1 paper)
- Partner nations
- TürkiyeUnited KingdomGreece
In The Last Decade
Mustafa Özdoğan
100 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 129
- Oncology 736
- Internal Medicine 94
- Endocrinology, Diabetes and Metabolism 292
- Cardiology and Cardiovascular Medicine 247
- Genetics 114
Countries citing papers authored by Mustafa Özdoğan
This map shows the geographic impact of Mustafa Özdoğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Özdoğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Özdoğan more than expected).
Fields of papers citing papers by Mustafa Özdoğan
This network shows the impact of papers produced by Mustafa Özdoğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Özdoğan. The network helps show where Mustafa Özdoğan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mustafa Özdoğan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2015 | 5 | |
| 6 | 2015 | 16 | |
| 7 | 2015 | 4 | |
| 8 | The importance of COX-2 expression as prognostic factor in early breast cancer. | 2014 | 12 |
| 9 | 2014 | 1 | |
| 10 | 2011 | 10 | |
| 11 | 2009 | 9 | |
| 12 | 2009 | 24 | |
| 13 | 2007 | 34 | |
| 14 | Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer. | 2005 | 7 |
| 15 | 2005 | 234 | |
| 16 | 2004 | 9 | |
| 17 | 2004 | 33 | |
| 18 | A Novel Method of Reporting c-erbB-2 Overexpression: Correlation with Grade But Not with Other Prognostic Parameters in Breast Cancer* | 2003 | 2 |
| 19 | 2003 | 36 | |
| 20 | 2001 | 27 |
About Mustafa Özdoğan
Mustafa Özdoğan is a scholar working on Oncology, Cancer Research and Geriatrics and Gerontology, having authored 106 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Diagnosis and Treatment (6 papers), Breast Cancer Treatment Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer survivorship and care (5 papers), Lung Cancer Diagnosis and Treatment (5 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Oncology (736 citations), Internal Medicine (94 citations) and Endocrinology, Diabetes and Metabolism (292 citations). Mustafa Özdoğan has collaborated with scholars based in Türkiye, United Kingdom and Greece. Frequent co-authors include Erkan Çoban, G. Yazicioglu, Ayşen Timurağaoğlu, Burhan Savaş, Hakan Bozcuk, Mehmet Artaç, Mustafa Samur, Erdinç Nayır, Hakan Bozcuk and Hasan Mutlu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.